The New Therapeutic Uses program aims to improve the process of developing new treatments and cures for disease by finding new uses for assets that already have cleared several key steps along the development path (also known as drug repurposing). Learn more.
New Therapeutic Uses Awards
NCATS announced nearly $3 million to fund four drug repurposing projects aimed at finding therapies for type 2 diabetes, glioblastoma, acute myeloid leukemia and Chagas disease.
Work with Us
Learn more about how you can access funding and collaborate with the New Therapeutic Uses program.
Discovering New Therapeutic Uses for Existing Molecules
About New Therapeutic Uses
Read more about the New Therapeutic Uses program and its progress.
Assets & Agreements
Access resources to get involved with the New Therapeutic Uses program.
New Therapeutic Uses and Drug Repurposing
Therapeutic development is a costly, complex and time-consuming process. The average length of time from target discovery to approval of a new drug is about 14 years. The failure rate during this process exceeds 95 percent, and the cost per successful drug can be $2 billion or more. The high therapeutic development failure rate means there are many existing, partially developed therapeutic candidates that could be repurposed for use in new disease indications. Bringing together the best assets from pharmaceutical companies with the best new ideas from academic researchers could produce new treatments much more quickly than starting from scratch. Learn more about the purpose of the New Therapeutic Uses program.